Celltrion to seek new drug, CDMO partners at int'l pharmaceutical exhibition in Milan

Celltrion, a Korean biopharmaceutical company, is attending the CPHI Worldwide exhibition in Milan next month to find new partners for its drug development, contract manufacturing, and supply chain needs. This event is one of the world's largest pharmaceutical trade shows, attracting over 60,000 industry professionals from around 170 countries. By seeking out new partners, Celltrion aims to expand its capabilities and stay competitive in the global market. This move could have positive implications for the company's growth and potentially benefit the economy through increased innovation and i…

Why it matters

Celltrion is seeking new partnerships for drug development and manufacturing. This could lead to increased collaboration and revenue for the company.

Market impact

Markets & countries in focus

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to The Korea Times. For information only — not financial advice.